Lexicon Pharmaceuticals, Inc. (LXRX)

CIK 1062822 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lexicon Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026EFFECT9999999995-26-002666
Aug 6, 2026S-30001193125-26-338409
Aug 6, 2026SCHEDULE 13G/A0000315066-26-002060
Aug 6, 2026S-80001062822-26-000119
Aug 6, 202610-Q0001062822-26-000117
Aug 6, 20268-K0001062822-26-000112
Jun 4, 202640001062822-26-000106
Jun 4, 202640001062822-26-000107
Jun 4, 202640001062822-26-000108
Jun 4, 202640001062822-26-000105
Jun 4, 202640001062822-26-000103
Jun 4, 202640001062822-26-000102
Jun 4, 202640001062822-26-000104
May 8, 202640001193125-26-215297
May 8, 2026SCHEDULE 13D/A0001193125-26-215295
May 7, 20268-K0001062822-26-000098
May 7, 202610-Q0001062822-26-000101
May 6, 20268-K0001062822-26-000094
May 4, 202640001062822-26-000067
May 4, 202640001062822-26-000090
May 4, 202640001062822-26-000092
May 4, 202640001062822-26-000082
May 4, 202640001062822-26-000075
May 4, 202640001062822-26-000080
May 4, 202640001062822-26-000084